NEW YORK, Aug. 30, 2017 -- The Nasdaq Stock Market announced today that it will delist the common stock of Crossroads Systems, Inc. Crossroads Systems, Inc.’s stock was suspended on August 23, 2017 and has not traded on Nasdaq since that time.
Nasdaq also announced that it will delist the common stock of Fenix Parts, Inc. Fenix Parts, Inc.’s stock was suspended on June 29, 2017 and has not traded on Nasdaq since that time.
Nasdaq also announced that it will delist the common stock of TerraVia Holdings, Inc. TerraVia Holdings, Inc.’s stock was suspended on August 11, 2017 and has not traded on Nasdaq since that time.
Finally, Nasdaq announced that it will delist the common stock of Function(x) Inc. Function(x) Inc.’s stock was suspended on June 22, 2017 and has not traded on Nasdaq since that time.
Nasdaq will file a Form 25 with the Securities and Exchange Commission to complete the delisting for each of these companies. The delistings become effective ten days after the Form 25 is filed. For news and additional information about the companies, including the basis for the delistings and whether the companies’ securities are trading on another venue, please review the companies’ public filings or contact the company directly.
For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaq’s rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: http://www.cchwallstreet.com/NasdaqTools/bookmark.asp?id=nasdaq-rule_5800&manual=/nasdaq/main/nasdaq-equityrules/.
NDAQO


Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure 



